Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 26 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 20, 2021 Filed Apr 21, 2021 20:31 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 27,905 | $120.09 | $3,351,024.94 |
DisclosureSEC source: 0001209191-21-027791 · doc4.xml · nonDerivative · entry 5 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,887 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $120.00 - $120.31. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| April 20, 2021 Filed Apr 21, 2021 20:31 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionCommon Stock | 27,905 | $41.59 | $1,160,568.95 |
DisclosureSEC source: 0001209191-21-027791 · doc4.xml · nonDerivative · entry 4 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| April 20, 2021 Filed Apr 21, 2021 20:31 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionCommon Stock | 1,492 | $67.00 | $99,964.00 |
DisclosureSEC source: 0001209191-21-027791 · doc4.xml · nonDerivative · entry 3 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 20:31 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 17,095 | $0.00 Strike: $41.59 | $0.00 |
DisclosureSEC source: 0001209191-21-027791 · doc4.xml · derivative · entry 7 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,990 Underlying: Common Stock · 17,095 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 20:31 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 17,095 | $120.07 | $2,052,678.71 |
DisclosureSEC source: 0001209191-21-027791 · doc4.xml · nonDerivative · entry 2 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,395 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $120.00 - $120.50. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 20:31 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionCommon Stock | 17,095 | $41.59 | $710,981.05 |
DisclosureSEC source: 0001209191-21-027791 · doc4.xml · nonDerivative · entry 1 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:33 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 2,570 | $0.00 Strike: $41.59 | $0.00 |
DisclosureSEC source: 0001209191-21-016001 · doc4.xml · derivative · entry 5 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 2,570 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:33 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 376 | $112.63 | $42,347.38 |
DisclosureSEC source: 0001209191-21-016001 · doc4.xml · nonDerivative · entry 4 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,685 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F4 · price: The price range for the aggregate amount sold by the direct holder is $112.61 - $112.67. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 35,034 shares of common stock and 6,651 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:33 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 300 | $111.80 | $33,539.01 |
DisclosureSEC source: 0001209191-21-016001 · doc4.xml · nonDerivative · entry 3 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,061 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $111.44 - $112.21. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:33 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 1,775 | $110.81 | $196,694.67 |
DisclosureSEC source: 0001209191-21-016001 · doc4.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,361 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $110.41 - $111.23. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:33 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionCommon Stock | 2,570 | $41.59 | $106,886.30 |
DisclosureSEC source: 0001209191-21-016001 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 16:53 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 2,415 | $0.00 Strike: $41.37 | $0.00 |
DisclosureSEC source: 0001209191-21-014792 · doc4.xml · derivative · entry 11 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,040 Underlying: Common Stock · 2,415 shares Expires 2024-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: These options are fully vested. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 16:53 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 52,581 | $0.00 Strike: $25.87 | $0.00 |
DisclosureSEC source: 0001209191-21-014792 · doc4.xml · derivative · entry 10 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,164 Underlying: Common Stock · 52,581 shares Expires 2023-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: These options are fully vested. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 16:53 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 36,955 | $0.00 Strike: $22.43 | $0.00 |
DisclosureSEC source: 0001209191-21-014792 · doc4.xml · derivative · entry 9 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,910 Underlying: Common Stock · 36,955 shares Expires 2022-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: These options are fully vested. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 16:53 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 40,130 | $111.54 | $4,476,236.64 |
DisclosureSEC source: 0001209191-21-014792 · doc4.xml · nonDerivative · entry 7 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,211,705 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F6 · price: The price range for the aggregate amount sold by the direct holder is $111.19 - $111.92. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F7 · balance_after: These shares are beneficially owned directly by Continental Power Exchange, Inc. ("CPEX"). Mr. Sprecher beneficially owns 100% of the equity interest in CPEX directly. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 16:53 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 19,870 | $110.73 | $2,200,272.66 |
DisclosureSEC source: 0001209191-21-014792 · doc4.xml · nonDerivative · entry 6 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,251,835 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F5 · price: The price range for the aggregate amount sold by the direct holder is $110.19 - $111.18. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 16:53 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 73,566 | $111.51 | $8,203,572.71 |
DisclosureSEC source: 0001209191-21-014792 · doc4.xml · nonDerivative · entry 5 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,365,390 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $111.10 - $111.89. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,293,878 shares of common stock and 71,512 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 16:53 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 35,471 | $110.71 | $3,927,075.99 |
DisclosureSEC source: 0001209191-21-014792 · doc4.xml · nonDerivative · entry 4 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,438,956 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $110.10 - $111.09. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 16:53 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 2,415 | $41.37 | $99,908.55 |
DisclosureSEC source: 0001209191-21-014792 · doc4.xml · nonDerivative · entry 3 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,474,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 16:53 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 52,581 | $25.87 | $1,360,270.47 |
DisclosureSEC source: 0001209191-21-014792 · doc4.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,472,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 16:53 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 36,955 | $22.43 | $828,900.65 |
DisclosureSEC source: 0001209191-21-014792 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,419,431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 21:34 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 1,433 | $111.35 | $159,562.69 |
DisclosureSEC source: 0001209191-21-013802 · doc4.xml · nonDerivative · entry 4 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,395 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F5 · price: The price range for the aggregate amount sold by the direct holder is $111.06 - $111.53. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F6 · balance_after: The common stock number referred in Table I is an aggregate number and represents 121,111 shares of common stock and 22,284 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 21:34 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 2,336 | $110.22 | $257,477.66 |
DisclosureSEC source: 0001209191-21-013802 · doc4.xml · nonDerivative · entry 3 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,828 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F4 · price: The price range for the aggregate amount sold by the direct holder is $109.72 - $110.71. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:34 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 365 | $111.92 | $40,850.76 |
DisclosureSEC source: 0001209191-21-013802 · doc4.xml · nonDerivative · entry 2 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,164 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $111.85 - $112.01. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:34 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 3,853 | $111.55 | $429,788.66 |
DisclosureSEC source: 0001209191-21-013802 · doc4.xml · nonDerivative · entry 1 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,529 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $110.85 - $111.83. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 18, 2021 Filed Feb 18, 2021 17:26 UTC |
Goone David SChief Strategic Officer
|
SaleCommon Stock | 2,247 | $113.79 | $255,692.65 |
DisclosureSEC source: 0001209191-21-011972 · doc4.xml · nonDerivative · entry 6 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,600 F3 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F7 · price: The price range for the aggregate amount sold by the direct holder is $113.40 - $114.12. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F8 · balance_after: The common stock number referred in Table I is an aggregate number and represents 167,651 shares of common stock and 23,949 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| February 18, 2021 Filed Feb 18, 2021 17:26 UTC |
Goone David SChief Strategic Officer
|
SaleCommon Stock | 2,844 | $112.82 | $320,858.37 |
DisclosureSEC source: 0001209191-21-011972 · doc4.xml · nonDerivative · entry 5 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,847 F3 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F6 · price: The price range for the aggregate amount sold by the direct holder is $112.39 - $113.34. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 18, 2021 Filed Feb 18, 2021 22:27 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 2,832 | $113.78 | $322,228.08 |
DisclosureSEC source: 0001209191-21-011975 · doc4.xml · nonDerivative · entry 6 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,504 F3 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F7 · price: The price range for the aggregate amount sold by the direct holder is $113.37 - $114.11. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F8 · balance_after: The common stock number referred in Table I is an aggregate number and represents 125,329 shares of common stock and 29,175 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| February 18, 2021 Filed Feb 18, 2021 22:27 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 3,310 | $112.85 | $373,538.13 |
DisclosureSEC source: 0001209191-21-011975 · doc4.xml · nonDerivative · entry 5 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,336 F3 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F6 · price: The price range for the aggregate amount sold by the direct holder is $112.37 - $113.33. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 16:41 UTC |
Namkung James WChief Accounting Officer
|
Tax withholdingCommon Stock | 465 | $113.86 | $52,944.90 |
DisclosureSEC source: 0001209191-21-012735 · doc4.xml · nonDerivative · entry 1 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,097 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 8, 2019. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2019 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 18, 2020, 1/3 on February 18, 2021 and 1/3 on February 18, 2022). Of the 3,084 shares remaining, 1,542 were issued on February 18, 2021, of which 465 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 1,542 shares are scheduled to be issued on February 18, 2022 and taxes for this future issuance will be withheld and reported at the time the shares are issued. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 13,349 shares of common stock and 2,760 unvested restricted stock units ("RSUs"), and 4,988 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 16:44 UTC |
Wassersug MarkChief Operating Officer
|
Tax withholdingCommon Stock | 1,160 | $113.86 | $132,077.60 |
DisclosureSEC source: 0001209191-21-012742 · doc4.xml · nonDerivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,808 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 8, 2019. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2019 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 18, 2020, 1/3 on February 18, 2021 and 1/3 on February 18, 2022). Of the 5,142 shares remaining, 2,571 were issued on February 18, 2021, of which 1,160 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 2,571 shares are scheduled to be issued on February 18, 2022 and taxes for this future issuance will be withheld and reported at the time the shares are issued. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 18,341 shares of common stock and 9,467 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 16:37 UTC |
Goone David SChief Strategic Officer
|
Tax withholdingCommon Stock | 2,528 | $113.86 | $287,838.08 |
DisclosureSEC source: 0001209191-21-012718 · doc4.xml · nonDerivative · entry 1 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,072 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 8, 2019. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2019 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 18, 2020, 1/3 on February 18, 2021 and 1/3 on February 18, 2022). Of the 11,313 shares remaining, 5,657 were issued on February 18, 2021, of which 2,528 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 5,656 shares are scheduled to be issued on February 18, 2022 and taxes for this future issuance will be withheld and reported at the time the shares are issued. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 170,780 shares of common stock and 18,292 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 16:42 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 10,046 | $113.86 | $1,143,837.56 |
DisclosureSEC source: 0001209191-21-012736 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,382,476 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 8, 2019. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2019 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 18, 2020, 1/3 on February 18, 2021 and 1/3 on February 18, 2022). Of the 44,226 shares remaining, 22,113 were issued on February 18, 2021, of which 10,046 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 22,113 shares are scheduled to be issued on February 18, 2022 and taxes for this future issuance will be withheld and reported at the time the shares are issued. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,310,964 shares of common stock and 71,512 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:38 UTC |
Hill Scott AChief Financial Officer
|
Tax withholdingCommon Stock | 3,122 | $113.86 | $355,470.92 |
DisclosureSEC source: 0001209191-21-012719 · doc4.xml · nonDerivative · entry 1 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,382 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 8, 2019. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2019 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 18, 2020, 1/3 on February 18, 2021 and 1/3 on February 18, 2022). Of the 13,782 shares remaining, 6,891 were issued on February 18, 2021, of which 3,122 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 6,891 shares are scheduled to be issued on February 18, 2022 and taxes for this future issuance will be withheld and reported at the time the shares are issued. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 129,098 shares of common stock and 22,284 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:43 UTC |
Surdykowski Andrew JGeneral Counsel
|
Tax withholdingCommon Stock | 929 | $113.86 | $105,775.94 |
DisclosureSEC source: 0001209191-21-012740 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,566 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 8, 2019. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2019 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 18, 2020, 1/3 on February 18, 2021 and 1/3 on February 18, 2022). Of the 4,114 shares remaining, 2,057 were issued on February 18, 2021, of which 929 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 2,057 shares are scheduled to be issued on February 18, 2022 and taxes for this future issuance will be withheld and reported at the time the shares are issued. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 34,915 shares of common stock and 6,651 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:40 UTC |
Martin Lynn CPresident, Fixed Income & Data
|
Tax withholdingCommon Stock | 1,511 | $113.86 | $172,042.46 |
DisclosureSEC source: 0001209191-21-012731 · doc4.xml · nonDerivative · entry 1 Martin Lynn C · CIK 0001754817 · President, Fixed Income & Data 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,779 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 8, 2019. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2019 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 18, 2020, 1/3 on February 18, 2021 and 1/3 on February 18, 2022). Of the 6,170 shares remaining, 3,085 were issued on February 18, 2021, of which 1,511 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 3,085 shares are scheduled to be issued on February 18, 2022 and taxes for this future issuance will be withheld and reported at the time the shares are issued. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 27,504 shares of common stock and 12,275 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:40 UTC |
Jackson BenjaminPresident
|
Tax withholdingCommon Stock | 2,569 | $113.86 | $292,506.34 |
DisclosureSEC source: 0001209191-21-012728 · doc4.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,703 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 8, 2019. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2019 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 18, 2020, 1/3 on February 18, 2021 and 1/3 on February 18, 2022). Of the 11,313 shares remaining, 5,657 were issued on February 18, 2021, of which 2,569 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 5,656 shares are scheduled to be issued on February 18, 2022 and taxes for this future issuance will be withheld and reported at the time the shares are issued. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 78,411 shares of common stock and 18,292 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:29 UTC |
Namkung James WChief Accounting Officer
|
Tax withholdingCommon Stock | 519 | $112.42 | $58,345.98 |
DisclosureSEC source: 0001209191-21-011981 · doc4.xml · nonDerivative · entry 2 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,562 F2 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 12,272 shares of common stock and 2,760 unvested restricted stock units ("RSUs"), and 6,530 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:29 UTC |
Namkung James WChief Accounting Officer
|
GrantCommon Stock | 5,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011981 · doc4.xml · nonDerivative · entry 1 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,081 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 7, 2020. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2020 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 16, 2021, 1/3 on February 16, 2022 and 1/3 on February 16, 2023). Of the 5,169 shares, 1,723 were issued on February 16, 2021, of which 519 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 3,446 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:31 UTC |
Wassersug MarkChief Operating Officer
|
Tax withholdingCommon Stock | 1,555 | $112.42 | $174,813.10 |
DisclosureSEC source: 0001209191-21-011987 · doc4.xml · nonDerivative · entry 2 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,968 F2 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 16,930 shares of common stock and 12,038 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:31 UTC |
Wassersug MarkChief Operating Officer
|
GrantCommon Stock | 10,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011987 · doc4.xml · nonDerivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,523 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 7, 2020. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2020 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 16, 2021, 1/3 on February 16, 2022 and 1/3 on February 16, 2023). Of the 10,338 shares, 3,446 were issued on February 16, 2021, of which 1,555 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 6,892 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:26 UTC |
Goone David SChief Strategic Officer
|
SaleCommon Stock | 4,778 | $112.06 | $535,433.67 |
DisclosureSEC source: 0001209191-21-011972 · doc4.xml · nonDerivative · entry 4 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,691 F3 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F5 · price: The price range for the aggregate amount sold by the direct holder is $111.74 - $112.50. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:26 UTC |
Goone David SChief Strategic Officer
|
SaleCommon Stock | 4,288 | $111.23 | $476,972.25 |
DisclosureSEC source: 0001209191-21-011972 · doc4.xml · nonDerivative · entry 3 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,469 F3 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F4 · price: The price range for the aggregate amount sold by the direct holder is $110.74 - $111.73. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:26 UTC |
Goone David SChief Strategic Officer
|
Tax withholdingCommon Stock | 2,810 | $112.42 | $315,900.20 |
DisclosureSEC source: 0001209191-21-011972 · doc4.xml · nonDerivative · entry 2 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,757 F2 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:26 UTC |
Goone David SChief Strategic Officer
|
GrantCommon Stock | 18,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011972 · doc4.xml · nonDerivative · entry 1 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,567 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 7, 2020. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2020 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 16, 2021, 1/3 on February 16, 2022 and 1/3 on February 16, 2023). Of the 18,955 shares, 6,319 were issued on February 16, 2021, of which 2,810 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 12,636 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:30 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 11,169 | $112.42 | $1,255,618.98 |
DisclosureSEC source: 0001209191-21-011984 · doc4.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,392,522 F2 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,298,897 shares of common stock and 93,625 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:30 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
GrantCommon Stock | 74,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011984 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,403,691 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 7, 2020. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2020 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 16, 2021, 1/3 on February 16, 2022 and 1/3 on February 16, 2023). Of the 74,099 shares, 24,700 were issued on February 16, 2021, of which 11,169 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 49,399 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:27 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 6,056 | $112.05 | $678,599.02 |
DisclosureSEC source: 0001209191-21-011975 · doc4.xml · nonDerivative · entry 4 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,646 F3 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F5 · price: The price range for the aggregate amount sold by the direct holder is $111.74 - $112.51. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:27 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 4,881 | $111.20 | $542,765.25 |
DisclosureSEC source: 0001209191-21-011975 · doc4.xml · nonDerivative · entry 3 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,702 F3 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F4 · price: The price range for the aggregate amount sold by the direct holder is $110.74 - $111.72. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:27 UTC |
Hill Scott AChief Financial Officer
|
Tax withholdingCommon Stock | 3,479 | $112.42 | $391,109.18 |
DisclosureSEC source: 0001209191-21-011975 · doc4.xml · nonDerivative · entry 2 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,583 F2 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.